skip to content
 

Overview

Cambridge researchers can now publish their review and primary research articles open access with no charge in journals that are part of deals referred to as "read & publish",  "transformative" agreements, or "transitional agreements".

 Authors submitting articles for publication in journals in these agreements will not be charged fees as the costs for open access publishing has been met centrally.

New deals and renewals are usually negotiated by JISC on the behalf of the UK JISC Consortia. The Journal Coordination Scheme considers each new deal (or renewal) on its merits, and the decision to sign up to a new deal or renew an existing one are taken by the Executive Committee, in consultation with the Steering Committee and Operational Group.

Terms of the agreements

All staff and students of the University may read journals published in the agreements. Researchers in the University may publish articles in the journals without incurring any article processing charge provided the following conditions are met:

  • The journal is a participating journal
  • The article type is covered by the deal (more detail on the terms of each deal can be found below)
  • The corresponding author is a researcher affiliated to the University of Cambridge (they should be the corresponding author at the time that the paper is considered for approval). We advise authors to use their @cam.ac.uk email address (or sub-domain in the format YourCRSid@xxxx.cam.ac.uk) in the publisher's submission system.

Please be aware that authors at Cambridge University Press and Cambridge Assessment are not eligible for the agreements. The deals do not cover visiting, honorary or emeritus researchers by default, but requests may be approved in exceptional circumstances. If in doubt, please contact the Open Access Team.

All articles submitted in the agreements are published under a Creative Commons Attribution 4.0 International (CC BY) licence by default. An exception may be made by notification to the publisher in the article submission process if you need to publish with a different licence.

If your article is not published open access, but you believe it should have been, please contact the Open Access Team immediately.

The following section provide details about each of these agreements, including a link for each to a list of the journals included for open access publishing.

 

Current "read & publish" agreements

Association for Computing Machinery (ACM)

The University has signed a transformative agreement with ACM to enable unlimited open access publishing in all of its journals, magazines and conferences for papers with a University of Cambridge corresponding author. This deal covers research articles and conference proceedings. This deal is in place from 1 January 2021 until 31 December 2022.

 

American Chemical Society (ACS)

The University has signed a transformative agreement with ACS to enable unlimited open access publishing in all of its journals. for papers with a University of Cambridge corresponding author. This deal covers research articles and is in place from 1 January 2022 until 31 December 2024. Articles with an acceptance date of 1 January 2022 or later that have been published behind the paywall will be made retrospectively OA through a CC license.

 

American Institute of Physics (AIP)

The University has signed a transformative agreement with AIP to enable open access publishing in their hybrid journals for papers with a University of Cambridge corresponding author. This deal covers research articles accepted from 1 January 2021 until 31 December 2023. Authors are advised that this deal does have an annual article cap. If the cap is reached, open access payments will be assessed on a case by case basis, according to funder mandates

 

American Physiological Society

The University has signed a transformative agreement with American Physiological Society, which provides unlimited open access in American Physiological Society's twelve hybrid journals for papers with a University of Cambridge corresponding author. This deal covers all article types and is in place from 1 January 2021 until 31 December 2022

 

Berghahn Open Anthro 

The University participates in Berghahn Open Anthro's subscribe-to-open pilot model. The pilot provides free open access publishing to authors in the participating journals. The model requires sufficient numbers of libraries to subscribe to the journals each year, and the publisher will confirm whether the model will operate each year at the beginning of the year. They have confirmed that the model will be operational in 2022. 

 

BioScientifica

The University has signed a transformative agreement with BioScientifica, which provides unlimited open access in BioScientifica's five hybrid journals for papers with a University of Cambridge corresponding author. This deal covers all article types and is in place from 1 January 2021 until 31 December 2022.

 

Brill

The University has signed a transitional agreement with Brill which provides for unlimited open access publishing of research and review articles by University of Cambridge corresponding authors in participating journals. Articles must be published on or after 1 January 2020 to be eligible. Eligibility will be determined at the point of submission. This deal covers research and review articles. This deal is in place from from 1 January 2021 until 31 December 2022.

 

Cambridge University Press

The University has signed a transitional agreement with Cambridge University Press to enable unlimited open access publishing of research, review, or rapid communication format articles by University of Cambridge corresponding authors. The deal is in place until 31 December 2024.

 

De Gruyter

The University has joined De Gruyter's Subscribe to Open Scheme, which allows unlimited open access for University of Cambridge corresponding authors publishing in participating journals. The model requires sufficient numbers of libraries to subscribe to the journals each year, and the publisher will confirm whether the model will operate each year at the beginning of the year.

 

Elsevier

The University has signed a transitional agreement agreement with Elsevier to enable unlimited open access for University of Cambridge corresponding authors publishing in participating hybrid journals, including Cell Press and the Lancet. The deal is in place for articles accepted from 1 January 2022 until 31 December 2024. In addition, University of Cambridge corresponding authors publishing in Elsevier's fully gold open access journals will receive a 15% discount on the Article Processing Charge (APC). Please note that review articles in some Cell Press and Lancet journals are excluded from the deal; please contact the Open Access Team info@openaccess.cam.ac.uk for further information. 

 

European Mathematical Society

The University has joined the European Mathematical Society's Subscribe to Open Scheme, which allows unlimited open access for University of Cambridge corresponding authors publishing in participating journals.

 

European Respiratory Society

The University has a signed a transitional agreement with the European Respiratory Society for unlimited open access publishing for all research articles by University of Cambridge corresponding authors in the European Respiratory Journal, the flagship journal of the European Respiratory Society. This deal is in place until 31 December 2023.

 

Institute of Physics Publishing

The University has signed a transitional agreement with the Institute of Physics that provides unlimited open access publishing of research articles by University of Cambridge corresponding authors from 1 January 2020 in 45 of the IOPP hybrid journals. The remaining “partner-hybrid” journals published by IOPP are expected to join the agreement from the start of 2021. This deal is in place from 1 January 2020 until 31 December 2023.

 

 

Journal of Medical Internet Research (JMIR)

The University has signed a flat fee agreement with JMIR, which provides unlimited open access publishing for University of Cambridge corresponding authors. The deal is in place from 1 April 2022 until 31 March 2024. In addition to the requirement for authors to use their @cam.ac.uk email address and Cambridge affiliation during the submission process (outlined in the introduction section above), to access the deal, authors should indicate in their cover letter that they are "requesting APC waiver through the Cambridge-JMIR OA deal via Jisc."

 

Microbiology Society

The University has renewed the transitional agreement with the Microbiology Society for unlimited, immediate open access publishing for research papers and review articles, where the corresponding author is affiliated with the University of Cambridge. The deal is in place until 31 December 2022.

 

Optica

The University has signed a transitional agreement with Optica for open access publishing of research and review articles in participating hybrid and fully open access journals. The deal operates an annual article cap, which is waived in the first year. The deal is in place until 31 December 2024. 

 

Oxford University Press

The University has signed a transitional agreement with Oxford University Press for open access publishing of research and review articles in all of OUP's participating journals for corresponding authors from the University of Cambridge. This is a 3 year agreement starting 1 January 2021 and is in place until 31 December 2023. 

 

Portland Press/Biochemical Society

The University has renewed the transitional agreement with Portland Press for an uncapped number of open access articles for research papers and review articles with a corresponding author from the University of Cambridge, in all seven of of Portland Press' journals (five hybrid titles plus two full-OA journals). The deal is in place until 31 December 2022.

 

Public Library of Science (PLOS)

The University of Cambridge has signed up to both the PLOS Flat Fee agreement and the PLOS Community Action Publishing agreement. Both deals provide unlimited open access publishing for University of Cambridge affiliated authors. 

Open Access fees for University of Cambridge corresponding authors will be covered for the following journals: PLOS ONE, PLOS Computational Biology, PLOS Genetics, PLOS Neglected Tropical Diseases, PLOS Pathogens, PLOS Digital Health, PLOS Climate, PLOS Water, and PLOS Global Public Health (via a flat fee agreement) and PLOS Medicine, PLOS Biology and PLOS Sustainability & Transformation (via the community action agreement). This deal is in place from 1 January 2021 until 31 December 2023.

 

Royal Society

The University has signed a transitional agreement with the Royal Society for an uncapped number of open access articles for research papers and review articles with a corresponding author from the University of Cambridge, in all ten of the Royal Society’s' journals (eight hybrid titles plus two full-OA journals). The Royal Society will apply the deal to unpublished papers that are in the review system between 1 January 2021 and the date of this agreement going live. This deal is in place from 1 January 2021 until 31 December 2022.

 

Royal Society of Chemistry (RSC)

The University has signed a transitional agreement with the Royal Society of Chemistry for unlimited open access publishing for University of Cambridge corresponding. The deal covers full papers, communications, and reviews published in the Royal Society of Chemistry's hybrid journals, and is in place until 31 December 2024.

 

SAGE

The University has signed a transitional agreement with SAGE for unlimited open access publishing in participating journals in SAGE's portfolio of hybrid journals for papers with a University of Cambridge corresponding author. The deal covers research papers and review articles and communication papers. This deal is in place from 1 January 2020 until 31 December 2022.

In addition, authors publishing in any of SAGE's fully open access journals will receive a 20% discount on the open access publication fee.

 

Springer

The University subscribes to the Springer Compact agreement for effectively unlimited open access publishing for University of Cambridge corresponding authors in participating journals across Springer's portfolio. This agreement covers the following article types: Original Paper (also referred to as  to as Original Research, Original Article, or Research Paper), Review Paper,  Brief Communication, and Continuing Education. This agreement is in place from 1 January 2019 until 31 December 2022.

 

The Company of Biologists

The University has renewed its Read & Publish Deal with The Company of Biologists. The deal provides read access, as well as unlimited, immediate open access publishing for all research and reviews articles by University of Cambridge corresponding authors in the Society’s three hybrid journals and two fully open access journals. This is a 3-year agreement covering 2022, 2023, and 2024 that is reviewed and evaluated annually.

 

Taylor & Francis

The University has signed a transitional agreement with Taylor & Francis that provides immediate open access publishing for all research and review articles by University of Cambridge corresponding authors in participating hybrid journals across Taylor & Francis' Social Sciences & Humanities, Science & Technology, and Medicine Collections. There is an annual funding cap in place for this agreement. This deal is in place from 1 January 2021 until 31 December 2023.

 

Wiley

The University has signed a transitional agreement with Wiley for open access publishing for corresponding authors from the University of Cambridge in participating journals across Wiley's portfolio. There is an annual funding cap which progressively transitions to 100% open access publishing over the term of the agreement. This agreement is in place from 1 January 2020 until 31 December 2023. The deal covers research and review articles. 

Wolters Kluwer

The University has signed a transitional agreement with Wolters Kluwer for open access publishing for corresponding authors from the University of Cambridge in participating hybrid journals. There is an annual funding cap. This agreement is in place from 1 January 2022 to 31 December 2024. This deal covers research and review articles.

 

How to get help and further advice

For any enquiry about the information on this page or for help in the article submission process please contact the Open Access Team.

Last updated 28/04/2022